Caplin Point Laboratories gets nod for slump sale of regulated markets injectable business
Caplin Point Laboratories has received an approval for the slump sale of business undertaking of the Company (Regulated Markets Injectable Business, including USFDA approved Injectable plant) to its wholly owned subsidiary company which is in the process of being incorporated. The Board of Directors of the company at their meeting held on November 19, 2018, … Read more
